Intimation under regulation 30 for appointment of Ms. Pooja Narendra Sanghavi as Non Executive Independent Director.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fredun Pharmaceuticals has appointed Ms. Pooja Narendra Sanghavi (DIN: 11387388) as an Additional Non-Executive Independent Director for a five-year term effective November 28, 2025, subject to shareholder approval. She is a qualified Company Secretary with expertise in corporate law, SEBI regulations, and compliance. In the same board meeting, Ms. Vaishnavi Sahu (ACS A78317), a Commerce Graduate and ICSI member, was appointed as the Company's new Company Secretary and Compliance Officer. Neither appointee is related to any existing director on the board. The appointments were recommended by the Nomination and Remuneration Committee and approved via board resolution.
Routine governance strengthening with the addition of an independent director with strong compliance background and a dedicated company secretary. No immediate material impact on shareholders, though shareholder approval will be sought for the independent director's appointment.